ALMR

Alamar Biosciences, Inc. NASDAQ

Healthcare ·Biotechnology ·US · alamarbio.com

$25.81

Mkt Cap $1.7B

52w Low $21.50 75.6% of range 52w High $27.20

50d MA $24.21 200d MA $24.21

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) —

ATR (14) —

Beta 0.00

50d MA $24.21

200d MA $24.21

Avg Volume 1.2M

About

Alamar Biosciences is a commercial-stage proteomics company focused on ultra-sensitive, multiplexed protein detection for research and future clinical applications. Its platform combines proprietary instruments, consumables, and software to provide an end-to-end system for measuring multiple low-abundance proteins across research and potential clinical applications.

Recent Filings

8-K

Alamar Biosciences, Inc. -- 8-K Filing

Alamar Biosciences raised approximately $219.9 million in its IPO, providing capital for operations and growth while establishing public market access.

Apr 20

Data updated apr 24, 2026 5:24pm · Source: massive.com